Enanta Pharmaceuticals Inc. buy Jefferies Financial Group Inc.
Start price
01.10.25
/
50%
€9.05
Target price
01.10.26
€17.04
Performance (%)
31.49%
Price
20.02.26
€11.70
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Enanta Pharmaceuticals Inc. has seen massive gains of 31.49%. This prediction currently runs until 01.10.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | 0.000% | 0.000% |
| iShares Core DAX® | 1,43 % | 2,63 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % |
| iShares S&P 500 | 1,92 % | 1,16 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.05
01.10.25
01.10.25
€17.04
01.10.26
01.10.26
31.49%
20.02.26
20.02.26

